1.
Clin Ter
; 97(4): 333-47, 1981 May 31.
Artigo
em Italiano
| MEDLINE
| ID: mdl-6113914
2.
Panminerva Med
; 23(2): 75-80, 1981.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7033893
Assuntos
Glicemia/biossíntese , Diabetes Mellitus/metabolismo , Glucagon/metabolismo , Glucose/farmacologia , Insulina/metabolismo , Nifedipino/farmacologia , Pâncreas/metabolismo , Piridinas/farmacologia , Idoso , Cálcio/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Pâncreas/efeitos dos fármacos
3.
Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
Horm Res
; 14(3): 148-54, 1981.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7286887
RESUMO
Nomifensine has recently been proposed as a dynamic test to discriminate tumoral from functional hyperprolactinaemia. In the present study, this test was performed in 9 subjects with radiological signs of sellar alteration and in 6 with no signs of pituitary lesion. Adopting the criterion reported in the previous study, the test was considered positive in 2 subjects of the first group and in 2 subjects of the second group. Therefore, our study indicates that the ability of this test to discriminate subjects with tumorous or non-tumorous hyperprolactinaemia still appears debatable.